P03366 (POL_HV1B1) Human immunodeficiency virus type 1 group M subtype B (isolate BH10)(HIV-1)
Gag-Pol polyprotein UniProtKBInterProInteractive Modelling
1447 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
414 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of AZT-resistant HIV-1 Reverse Transcriptase crosslinked to a DSDNA with a bound … |
Heteromer | 2×MG; 1×ZP4; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase (RT) in complex with THR-50 |
Heteromer | 1×T50; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase covalently tethered to DNA template-primer solved … |
Heteromer P01868; | 2×GOL; 1×MG; 1×GLC; | ||||
| Assess | ||||||
| HIV-1 REVERSE TRANSCRIPTASE/FRAGMENT OF FAB 28/DNA COMPLEX |
Heteromer | |||||
| Assess | ||||||
| STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN A COMPLEX WITH THE NONNUCLEOSIDE INHIBITOR ALPHA-APA R … |
Heteromer P03367; | 1×AAA; | ||||
| Assess | ||||||
| Crystal structure of AZT-Resistant HIV-1 Reverse Transcriptase crosslinked to post-translocation AZ… |
Heteromer | 1×MG; | ||||
| Assess | ||||||
| STRUCTURE OF HIV-1 RT(SLASH)TIBO R 86183 COMPLEX REVEALS SIMILARITY IN THE BINDING OF DIVERSE NONNU… |
Heteromer | 1×TBO; | ||||
| Assess | ||||||
| HIV-1 Reverse Transcriptase Crosslinked to pre-translocation AZTMP-terminated DNA (complex N) |
Heteromer I6L991; P01868; | 2×MG; | ||||
| Assess | ||||||
| Crystal Structure of K103N/Y181C Mutant HIV-1 Reverse Transcriptase (RT) in Complex with Nonnucleos… |
Heteromer | 1×MN; 1×HBY; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase crosslinked to tenofovir terminated template-primer (complex P) |
Heteromer | 1×MG; | ||||
| Assess | ||||||
| HIV-1 Reverse Transcriptase Crosslinked to Post-Translocation AZTMP-Terminated DNA (Complex P) |
Heteromer P01837; P01868; | 1×MG; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDE… |
Heteromer | |||||
| Assess | ||||||
| Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhib… |
Heteromer | 1×NNC; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 RT bound to A 6-vinylpyrimidine inhibitor |
Heteromer | 1×EDM; | ||||
| Assess | ||||||
| Crystal structure of the HIV-1 reverse transcriptase bound to a 6-vinylpyrimidine inhibitor |
Heteromer | 1×EDM; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE TRANSCRIPTASE |
Heteromer | |||||
| Assess | ||||||
| +1 extended HIV-1 reverse transcriptase initiation complex core (pre-translocation state) |
Heteromer P04585; | |||||
| Assess | ||||||
| Structure of HIV-1 reverse transcriptase initiation complex core with nevirapine |
Heteromer | 1×MG; 1×NVP; | ||||
| Assess | ||||||
| Crystal Structure of an N-Hydroxythienopyrimidine-2,4-dione RNase H Active Site Inhibitor with Mult… |
Heteromer | 2×MN; 1×ZW2; 5×PGE; 33×EDO; | ||||
| Assess | ||||||
| Structure of HIV-1 Reverse Transcriptase (RT) in complex with dsDNA and (-)3TC-TP |
Heteromer | 2×MG; 3×SO4; 1×1RZ; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 3-(2-((2-cyanoindolizin-8-yl)oxy)p… |
Heteromer | 1×VOI; 2×PO4; 1×MG; | ||||
| Assess | ||||||
| STRUCTURAL BASIS OF ASYMMETRY IN THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE HETE… |
Heteromer | 1×NVP; | ||||
| Assess | ||||||
| +3 extended HIV-1 reverse transcriptase initiation complex core (intermediate state) |
Heteromer P04585; | |||||
| Assess | ||||||
| Structure of HIV-1 reverse transcriptase initiation complex core with efavirenz |
Heteromer | 1×MG; 1×EFZ; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase (RT) in complex with Rilpivirine (TMC278, Edurant)… |
Heteromer | 1×T27; 6×SO4; 5×EDO; 1×MG; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase with bound fragment at the incoming dNTP binding site |
Heteromer | 1×T27; 1×MG; 11×DMS; 1×14N; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase/rilpivirine with bound fragment 1-N-methyl-4-(trifluoromethyl)benzene-1… |
Heteromer | 1×T27; 6×DMS; 3×EDO; 1×MG; 1×U43; 4×SO4; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase/rilpivirine with bound fragment 5-fluoroquinazolin-4-ol at W266 site |
Heteromer | 1×JBQ; 1×T27; 12×DMS; 2×EDO; 1×MG; 2×SO4; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase/rilpivirine with bound fragment 2-amino-6-fluorobenzonitrile at the NNR… |
Heteromer | 1×0IF; 1×T27; 7×DMS; 3×EDO; 1×MG; 2×SO4; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase/rilpivirine with bound fragment 2-chloro-6-fluorophenethylamine at the … |
Heteromer | 1×W15; 1×T27; 7×DMS; 3×EDO; 1×MG; 5×SO4; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase with bound fragment at NNRTI adjacent site |
Heteromer | 1×1QP; 10×DMS; 1×T27; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 K103N mutant reverse transcriptase in complex with non-nucleoside inhibi… |
Heteromer | 1×K5C; 1×MG; 10×SO4; 14×EDO; 1×DMS; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase in complex with non-nucleoside inhibitor K-5a2 |
Heteromer | 1×K5A; 1×MG; 7×SO4; 23×EDO; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 Y188L mutant reverse transcriptase in complex with non-nucleoside inhibi… |
Heteromer | 1×K5A; 1×MG; 1×NA; 7×SO4; 23×EDO; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase with bound fragment at the RNase H primer grip site |
Heteromer | 1×T27; 17×DMS; 1×1FF; 1×MG; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH an anilinylpyrimidine derivat… |
Heteromer | 1×JLJ; 2×SO4; 2×EDO; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase with bound fragment near Knuckles site |
Heteromer | 1×T27; 15×DMS; 1×J94; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 E138K mutant reverse transcriptase in complex with non-nucleoside inhibi… |
Heteromer | 1×K5A; 1×MG; 1×NA; 8×SO4; 26×EDO; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase/rilpivirine with bound fragment [1-(4-fluorophenyl)-5-methyl-1H-pyrazol… |
Heteromer | 1×T27; 7×DMS; 3×EDO; 1×MG; 2×FMQ; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 K103N mutant reverse transcriptase in complex with non-nucleoside inhibi… |
Heteromer | 1×K5A; 1×MG; 2×DMS; 10×SO4; 30×EDO; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase V106A/F227L mutant in complex with non-nucleoside … |
Heteromer | 1×K5C; 1×MG; 9×SO4; 18×EDO; 1×DMS; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase/rilpivirine with bound fragment 4-bromophenol at the Knuckles site |
Heteromer | 1×BML; 1×T27; 9×DMS; 1×MG; 3×SO4; 1×EDO; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase/rilpivirine with bound fragment 4-amino-3-bromopyridine at multiple sit… |
Heteromer | 1×T27; 5×DMS; 4×EDO; 1×MG; 4×V06; 4×SO4; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase/rilpivirine with bound fragment 4-bromopyrazole at multiple sites |
Heteromer | 1×T27; 6×DMS; 3×EDO; 1×MG; 4×SO4; 8×BYZ; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase in complex with non-nucleoside inhibitor 25a |
Heteromer | 1×K5C; 1×MG; 8×SO4; 22×EDO; 1×DMS; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase Y181I mutant in complex with non-nucleoside inhibi… |
Heteromer | 1×K5C; 1×MG; 8×SO4; 28×EDO; 1×DMS; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 RT in Complex with 16c (K07-15) |
Heteromer | 6×SO4; 5×EDO; 1×MG; 1×K7F; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 K103N/Y181C mutant reverse transcriptase in complex with non-nucleoside … |
Heteromer | 1×K5C; 1×MG; 8×SO4; 31×EDO; 1×DMS; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 E138K mutant reverse transcriptase in complex with non-nucleoside inhibi… |
Heteromer | 1×K5C; 1×MG; 9×SO4; 27×EDO; 1×DMS; | ||||
| Assess | ||||||
| Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-Ray Crystallographic Fragment Screen… |
Heteromer | 1×T27; 2×FMQ; 11×DMS; 1×MG; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase/rilpivirine with bound fragment 3-bromobenzylamine in the thumb subdoma… |
Heteromer | 1×4JH; 1×T27; 9×DMS; 3×EDO; 1×MG; 3×SO4; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase with bound fragment at the 428 site |
Heteromer | 1×T27; 1×1FE; 1×MG; 16×DMS; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase/rilpivirine with bound fragment 5-fluoroindole-2-carboxylic acid at the… |
Heteromer | 2×FIC; 1×T27; 9×DMS; 3×EDO; 1×MG; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase with bound fragment at the Knuckles site |
Heteromer | 1×T27; 1×MG; 16×DMS; 1×1FD; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase complexed with 4-iodopyrazole |
Heteromer | 1×T27; 4×SO4; 4×EDO; 14×IOD; 6×PYZ; 5×DMS; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase/rilpivirine with bound fragment 5-(trifluoromethyl)pyridin-2-ol at W24 … |
Heteromer | 1×U4D; 1×T27; 9×DMS; 3×EDO; 1×MG; 3×SO4; | ||||
| Assess | ||||||
| Structure of HIV-1 reverse transcriptase (RT) in complex with rilpivirine and an RNase H inhibitor … |
Heteromer | 1×T27; 1×BA5; 2×MG; 2×SO4; 1×EDO; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase K101P mutant in complex with non-nucleoside inhibi… |
Heteromer | 1×K5C; 1×MG; 9×SO4; 24×EDO; 1×DMS; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase (RT) in complex with 4-[(4-{4-[(E)-2-cyanoethenyl]… |
Heteromer | 1×QAG; 7×SO4; 6×EDO; 1×MG; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase/rilpivirine with bound fragment 4-iodopyrazole at multiple sites |
Heteromer | 1×T27; 5×DMS; 5×EDO; 1×MG; 4×SO4; 3×PYZ; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 5-(2-(2-(3-acryloyl-2-oxo-2,3-dihy… |
Heteromer | 1×VO8; 3×PO4; 2×MG; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with JLJ353 |
Heteromer | 1×LE8; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with N-(4-chloro-3-(3-chloro-5-cyanophe… |
Heteromer | 1×VTV; 1×MG; 1×SO4; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 RT in Complex with NBD-14189 |
Heteromer | 4×SO4; 3×DMS; 1×YBA; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with N-(4-chloro-3-(3-chloro-5-cyanophe… |
Heteromer | 1×VTN; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase (RT) in complex with VM-1500A, a non-nucleoside RT… |
Heteromer | 1×VM5; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase in complex with non-nucleoside inhibitor 19980 |
Heteromer | 1×DMS; 1×XU9; 3×EDO; 3×SO4; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 RT in Complex with NBD-14270 |
Heteromer | 4×SO4; 1×YB7; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with N-(2-(2-((2-cyanoindolizin-8-yl)ox… |
Heteromer | 1×VVN; 3×MG; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with5-(2-(3-oxo-3-(pyrrolidin-1-yl)prop… |
Heteromer | 1×VWB; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with N-(2-(5-chloro-2-((6-cyanonaphthal… |
Heteromer | 1×VRQ; 3×MG; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase with bound fragment at the 507 site |
Heteromer | 2×1FG; 4×DMS; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 7-(2-(2-(2,4-dioxo-3,4-dihydropyri… |
Heteromer | 1×UMY; 4×SO4; 1×MG; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 RT in Complex with the non-nucleoside inhibitor 18b1 |
Heteromer | 1×XRB; 6×SO4; 1×EDO; | ||||
| Assess | ||||||
| STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INC… |
Heteromer | 1×GLC; 2×MG; 1×DTP; 1×SO4; 3×EDO; | ||||
| Assess | ||||||
| STRUCTURE OF Q151M complex (A62V, V75I, F77L, F116Y, Q151M) mutant HIV-1 REVERSE TRANSCRIPTASE (RT)… |
Heteromer | 1×GLC; 2×MG; 1×DTP; 1×EDO; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of the HIV-1 reverse transcriptase (RT) in complex with the alkenyldiarylmethane … |
Heteromer | 1×AC7; | ||||
| Assess | ||||||
| STRUCTURE OF Q151M MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED D… |
Heteromer | 1×GLC; 2×MG; 1×DTP; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 RT in Complex with NBD-14075 |
Heteromer | 1×YBD; 3×SO4; | ||||
| Assess | ||||||
| STRUCTURE OF Q151M complex (A62V, V75I, F77L, F116Y, Q151M) mutant HIV-1 REVERSE TRANSCRIPTASE (RT)… |
Heteromer | 1×GLC; 2×MG; 1×DDS; 1×SO4; 2×EDO; | ||||
| Assess | ||||||
| Structure of HIV-1 Reverse Transcriptase in complex with DNA, L-dTTP, and CA(2+) ion |
Heteromer | 1×GLC; 1×CA; 1×SO4; 2×GOL; 1×XRF; 1×NH4; | ||||
| Assess | ||||||
| STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INC… |
Heteromer | 1×GLC; 2×MG; 1×DDS; 4×EDO; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase (RT) cross-linked with AZT-terminated DNA |
Heteromer | |||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with N-(2-(2-((6-cyanonaphthalen-1-yl)o… |
Heteromer | 1×VRF; 2×MG; 1×PO4; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase (RT) with DNA and AZTTP |
Heteromer | 1×MG; 1×AZT; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 reverse transcriptase (RT) in complex with the Non-nucleoside RT Inhibit… |
Heteromer | 1×UDR; | ||||
| Assess | ||||||
| Structure of HIV-1 Reverse Transcriptase Bound to a 38-mer Hairpin Template-Primer RNA-DNA Aptamer |
Heteromer | 1×GLC; 1×MG; 4×GOL; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase with a double stranded DNA showing a transient P-p… |
Heteromer | 16×CD; 2×SO4; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase (RT) with DNA and the nonnucleoside inhibitor nevi… |
Heteromer | 1×NVP; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase (RT) with DNA and a nucleoside triphosphate mimic … |
Heteromer | 1×GLC; 3×MG; 1×3JY; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase in complex with RNA/DNA and Nevirapine |
Heteromer | 1×NVP; | ||||
| Assess | ||||||
| STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE In COMPLEX WITH A 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAM… |
Heteromer | 1×GLC; 2×MG; 1×64A; 1×SO4; 6×GOL; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase in complex with bulge-RNA/DNA and Nevirapine |
Heteromer | 1×NVP; 1×CA; 1×SO4; | ||||
| Assess | ||||||
| K65R mutant HIV-1 reverse transcriptase cross-linked to DS-DNA and complexed with tenofovir-diphosp… |
Heteromer | 1×TNV; 2×MG; 2×SO4; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase crosslinked to template-primer with tenofovir-diphosphate bound as the … |
Heteromer P04585; | 2×MG; 1×TNV; 5×GOL; | ||||
| Assess | ||||||
| Crystal Structure of a Dihydroxycoumarin RNase H Active-Site Inhibitor in Complex with HIV-1 Revers… |
Heteromer | 1×NVP; 1×F95; 2×MN; | ||||
| Assess | ||||||
| Structure of HIV-1 Reverse Transcriptase in complex with DNA, dTTP, and CA(2+) ion |
Heteromer | 1×TTP; 1×CA; 5×GOL; 1×SO4; | ||||
| Assess | ||||||
| Crystal Structure of K103N/Y181C Mutant HIV-1 Reverse Transcriptase (RT) in Complex with IDX899 |
Heteromer | 1×5DV; | ||||
| Assess | ||||||
| THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
Heteromer | 1×MG; | ||||
| Assess | ||||||
| STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG… |
Heteromer P04585; | 4×MG; 1×TTP; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase with a double stranded DNA in complex with fragmen… |
Heteromer | 9×CD; | ||||
| Assess | ||||||
| Structure of HIV-1 Reverse Transcriptase in complex with a DNA aptamer, AZTTP, and CA(2+) ion |
Heteromer | 1×CA; 1×AZT; | ||||
| Assess | ||||||
| K65R mutant HIV-1 reverse transcriptase cross-linked to DS-DNA and complexed with DATP as the incom… |
Heteromer | 1×DTP; 2×SO4; 2×MG; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase in complex with gap-RNA/DNA and Nevirapine |
Heteromer | 1×NVP; 1×MN; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase with a double stranded DNA in complex with fragmen… |
Heteromer | 1×GLC; 9×CD; | ||||
| Assess | ||||||
| Crystal structure of AZT-resistant HIV-1 Reverse Transcriptase crosslinked to pre-translocation AZT… |
Heteromer | |||||
| Assess | ||||||
| Structure of HIV-1 reverse transcriptase initiation complex core |
Heteromer | 1×MG; 1×BOG; | ||||
| Assess | ||||||
| Cryo-EM structure of NNRTI resistant M184I/E138K mutant HIV-1 reverse transcriptase with a DNA apta… |
Heteromer | 1×T27; | ||||
| Assess | ||||||
| Structure of HIV-1 Reverse Transcriptase Bound to a Novel 38-mer Hairpin Template-Primer DNA Aptamer |
Heteromer | 1×GLC; 1×SO4; 6×GOL; | ||||
| Assess | ||||||
| Structure of HIV-1 Reverse Transcriptase in complex with DNA and INDOPY-1 |
Heteromer | 1×GLC; 4×SO4; 1×NH4; 2×GOL; 2×PEG; 1×PG4; 1×IY1; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 3-chloro-5-(4-chloro-2-(2-(5-chlor… |
Heteromer | 1×VQ0; | ||||
| Assess | ||||||
| Structure of HIV-1 Reverse Transcriptase in complex with DNA, (-)FTC-TP, and CA(2+) ion |
Heteromer | 1×GLC; 2×SO4; 7×GOL; 1×PG4; 1×NH4; 1×CA; 1×1RY; | ||||
| Assess | ||||||
| STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INC… |
Heteromer | 2×MG; 1×D4T; 6×GOL; | ||||
| Assess | ||||||
| STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INC… |
Heteromer | 2×MG; 1×D4T; 7×GOL; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with N-(6-cyano-3-(2-(2-(2,4-dioxo-3,4-… |
Heteromer | 1×9KD; 1×SO4; | ||||
| Assess | ||||||
| STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INC… |
Heteromer | 2×MG; 1×D4T; 7×GOL; | ||||
| Assess | ||||||
| STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INC… |
Heteromer | 2×MG; 1×D4T; 7×GOL; | ||||
| Assess | ||||||
| STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INC… |
Heteromer | 2×MG; 1×D4T; 7×GOL; | ||||
| Assess | ||||||
| STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INC… |
Heteromer | 2×MG; 1×D4T; 7×GOL; | ||||
| Assess | ||||||
| STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INC… |
Heteromer | 2×MG; 1×D4T; 8×GOL; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 2-chloro-N-(4-chloro-3-(3-chloro-5… |
Heteromer | 1×VWU; | ||||
| Assess | ||||||
| Structure of HIV-1 Reverse Transcriptase in complex with DNA, L-dCTP, and CA(2+) ion |
Heteromer | 1×GLC; 1×SO4; 1×1S0; 1×CA; 1×NH4; 1×GOL; | ||||
| Assess | ||||||
| STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE In COMPLEX WITH A DNA aptamer and FOSCARNET, a Pyrophospha… |
Heteromer | 1×GLC; 4×MG; 1×PPF; 1×SO4; 2×GOL; 1×ATM; | ||||
| Assess | ||||||
| Crystal Structure of a Hydroxypyridone Carboxylic Acid Active-Site RNase H Inhibitor in Complex wit… |
Heteromer | 1×MG; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 3-(2-(2-(3-acryloyl-2-oxo-2,3-dihy… |
Heteromer | 1×VVE; 2×PO4; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A POLYPURINE TRACT RNA:DNA |
Heteromer | |||||
| Assess | ||||||
| Crystal Structure of a 2-Hydroxyisoquinoline-1,3-dione RNase H Active Site Inhibitor with Multiple … |
Heteromer | 2×MN; 1×Y55; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (Y181C, V106A) varient in Complex with 5-(2-(2-(2,… |
Heteromer | 1×7N1; 1×MG; | ||||
| Assess | ||||||
| Structure of HIV-1 Reverse Transcriptase in complex with DNA, dCTP, and CA(2+) ion |
Heteromer | 1×GLC; 1×SO4; 6×GOL; 1×DCP; 1×CA; | ||||
| Assess | ||||||
| Crystal structure of wild-type HIV-1 Reverse Transcriptase crosslinked to a DSDNA with a bound exci… |
Heteromer | 2×MG; 1×ZP4; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (RT) in Complex with TMC278 (Rilpivirine), A Non-n… |
Heteromer | 1×SO4; 1×T27; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of an engineered form of the HIV-1 Reverse Transcriptase, RT69A |
Heteromer | 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of K103N/Y181C mutant HIV-1 reverse transcriptase (RT) in complex with TMC278 (Ri… |
Heteromer | 1×T27; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (K103N, Y181C) Variant in Complex with 2-chloro-N-… |
Heteromer | 1×9HY; 1×SO4; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with N-(2-(4-chloro-3-(3-chloro-5-cyano… |
Heteromer | 1×VTS; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (K103N, Y181C) Variant in Complex with N-(6-cyano-… |
Heteromer | 1×9J1; 2×SO4; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with (JLJ729), a non-nucleoside inhibit… |
Heteromer | 1×VQK; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) Variant in Complex with 2-chloro-N-(6-cyan… |
Heteromer | 1×9HY; 2×SO4; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase (RT) in complex with R221239 |
Heteromer | 2×GLC; 2×GOL; 1×MN; 1×R22; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) Variant in Complex with N-(6-cyano-3-(2-(2… |
Heteromer | 1×9KD; 1×SO4; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) Variant in Complex with 5-chloro-7-(2-(2-(… |
Heteromer | 1×7AY; 2×SO4; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with N-(6-cyano-3-(2-(2-(2,4-dioxo-3,4-… |
Heteromer | 1×9JP; 1×SO4; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with N-(6-cyano-3-(2-(2-(2,4-dioxo-3,4-… |
Heteromer | 1×9KG; 1×SO4; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 2-chloro-N-(6-cyano-3-(2-(2-(2,4-d… |
Heteromer | 1×9K7; 1×SO4; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) Variant in Complex with N-(6-cyano-3-(2-(2… |
Heteromer | 1×9J1; 1×SO4; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) Variant in Complex with N-(6-cyano-3-(2-(2… |
Heteromer | 1×9JP; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 Reverse Transcriptase (RT) in complex with TSAO-T, a non-nucleoside RT i… |
Heteromer | 1×QO9; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with methyl 2-(6-cyano-3-(2-(2-(2,4-dio… |
Heteromer | 1×UMV; 3×SO4; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R129385 |
Heteromer | 1×ADB; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) variant in complex with (E)-3-(3-chloro-5-… |
Heteromer | 1×494; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 5-(cyclopropylmethyl)-7-(2-(2-(2,4… |
Heteromer | 1×UO4; 2×SO4; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (K103N,Y181C) variant in complex with (E)-3-(3-chl… |
Heteromer | 1×494; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with N-(2-(5-chloro-2-(3-chloro-5-cyano… |
Heteromer | 1×VU8; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 5-chloro-7-(2-(2-(2,4-dioxo-3,4-di… |
Heteromer | 1×7AY; 1×SO4; 1×MG; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in complex with 4-((4-(mesitylamino)-1,3,5-triazin… |
Heteromer | 1×2RT; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) Variant in Complex with methyl 2-(6-cyano-… |
Heteromer | 1×UMV; 1×SO4; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with (E)-4-((4-((4-(2-cyanovinyl)-2,6-d… |
Heteromer | 1×9W3; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) Variant in Complex with 7-(2-(2-(2,4-dioxo… |
Heteromer | 1×7AX; 1×SO4; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase K103N/Y181C Variant in Complex with (E)-4-((4-((4-… |
Heteromer | 1×9W3; 1×MG; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 7-(2-(2-(2,4-dioxo-3,4-dihydropyri… |
Heteromer | 1×7AX; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 3-(2-(2-(3-acryloyl-2-oxo-2,3-dihy… |
Heteromer | 1×VVE; 2×MG; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 K103N, Y181C mutant Reverse Transcriptase in Complex with 5-(2-(2-(2,4-d… |
Heteromer | 1×M9A; 1×MG; | ||||
| Assess | ||||||
| HIV-1 Reverse Transcriptase with the Inhibitor beta-Thujaplicinol Bound at the RNase H Active Site |
Heteromer | 1×JTH; 2×MN; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 6-((4-((4-cyanophenyl)amino)-1,3,5… |
Heteromer | 1×639; 2×SO4; 1×MG; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 7-(2-(2-(2,4-dioxo-3,4-dihydropyri… |
Heteromer | 1×UNS; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in complex with 4-((4-(mesitylamino)-6-(3-morpholi… |
Heteromer | 1×2RS; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 4-((4-methoxy-6-(2-morpholinoethox… |
Heteromer | 1×1RE; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase (RT) in complex with JANSSEN-R165481 |
Heteromer | 1×MN; 1×3AC; | ||||
| Assess | ||||||
| Crystal structure of L100I/K103N mutant HIV-1 reverse transcriptase (RT) in complex with TMC278 (ri… |
Heteromer | 1×T27; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase (RT) in complex with JANSSEN-R157208 |
Heteromer | 1×MN; 1×357; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Y181C mutant Reverse Transcriptase in Complex with 5-(2-(2-(2,4-dioxo-3,… |
Heteromer | 1×M9A; 1×SO4; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) varient in Complex with 5-(2-(2-(2,4-dioxo… |
Heteromer | 1×3LQ; 2×MG; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) variant in complex with (E)-3-(3-chloro-5-… |
Heteromer | 1×3X6; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 8-(2-(3-morpholino-3-oxopropoxy)ph… |
Heteromer | 1×VPB; 2×PO4; 1×MG; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (K103N, Y181C) variant in complex with (E)-3-(3-ch… |
Heteromer | 1×3X6; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase Y181C Variant in Complex with (E)-4-((4-((4-(2-cya… |
Heteromer | 1×9W3; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase (RT) in complex with DHBNH, an RNASE H inhibitor |
Heteromer Q8UM83; | 2×GLC; 3×GLC; 1×K05; 1×MG; | ||||
| Assess | ||||||
| Cryo-EM structure of NNRTI resistant M184I/E138K mutant HIV-1 reverse transcriptase with a DNA apta… |
Heteromer | 1×NVP; | ||||
| Assess | ||||||
| Crystal Structure of K103N/Y181C Mutant HIV-1 Reverse Transcriptase (RT) in Complex with ATP |
Heteromer | 3×MN; 1×NA; 1×ATP; 2×GOL; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 8-(2-(3-oxo-3-(pyrrolidin-1-yl)pro… |
Heteromer | 1×VOU; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (Y181C, V106A) varient in Complex with 8-(2-(2-(2,… |
Heteromer | 1×MG; 1×29T; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with N-(2-(2-((6-chloro-2-cyanoindolizi… |
Heteromer | 1×VW2; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with N-(2-(5-chloro-2-((2-cyanoindolizi… |
Heteromer | 1×VR9; 1×MG; | ||||
| Assess | ||||||
| Crystal structure of unliganded AZT-resistant HIV-1 Reverse Transcriptase |
Heteromer | |||||
| Assess | ||||||
| STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE In COMPLEX WITH A DNA aptamer and an Alpha-carboxy nucleos… |
Heteromer | 1×GLC; 3×MG; 1×3JY; 5×SO4; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (Y181C, V106A) variant in Complex with 5-(2-(2-(2,… |
Heteromer | 2×SO4; 1×EDO; 1×3LQ; | ||||
| Assess | ||||||
| Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhib… |
Heteromer | 1×NNI; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 3-(2-((2-cyanoindolizin-8-yl)oxy)p… |
Heteromer | 1×VP2; 1×PO4; | ||||
| Assess | ||||||
| Diabody bound to a Reverse Transcriptase Aptamer Complex |
Heteromer | 11×SO4; 1×GOL; | ||||
| Assess | ||||||
| Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhib… |
Heteromer | 1×NNB; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with (E)-4-(3-(2-cyanovinyl)-5-fluoroph… |
Heteromer | 1×X2G; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with (E)-4-(3-chloro-5-(2-cyanovinyl)ph… |
Heteromer | 1×X2J; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 4-(3-chloro-5-cyanophenoxy)-3-(2-(… |
Heteromer | 1×X2S; | ||||
| Assess | ||||||
| HIV-1 Reverse Transcriptase Y181C Mutant in complex with JLJ 578 |
Heteromer | 1×H9Y; 1×MG; 1×SO4; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (Y181C, V106A) variant in Complex with 8-(2-(2-(2,… |
Heteromer | 1×MG; 1×H9Y; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 5-(2-(2-(2,4-dioxo-3,4-dihydropyri… |
Heteromer | 1×7N1; 1×MG; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 5-(2-(2-(2,4-dioxo-3,4-dihydropyri… |
Heteromer | 1×M9A; 1×MG; 1×SO4; | ||||
| Assess | ||||||
| STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE N-SITE COMPLEX; CATALYTIC INCORPORATION OF AZTMP to A DNA … |
Heteromer | 1×GLC; 1×MG; 2×GOL; | ||||
| Assess | ||||||
| Cryo-EM structure of NNRTI resistant M184I/E138K mutant HIV-1 reverse transcriptase with a DNA apta… |
Heteromer | 1×2KW; | ||||
| Assess | ||||||
| Architecture of HIV-1 reverse transcriptase initiation complex core |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase (RT) with polymorphism mutation K172A and K173A |
Heteromer | 4×MG; 14×EDO; 6×GOL; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 6-((2-((4-cyanophenyl)amino)pyrimi… |
Heteromer | 1×9WI; 2×SO4; 4×MG; 1×PUT; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with (E)-3-(3-(4-chloro-2-(2-(2,4-dioxo… |
Heteromer | 1×1YQ; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with (E)-3-(3-chloro-5-(4-chloro-2-(2-(… |
Heteromer | 1×494; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with (E)-3-(3-chloro-5-(2-(2-(2,4-dioxo… |
Heteromer | 1×9UV; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (RT) in Complex with (E)-3-(3-(2-(2-(2,4-dioxo-3,4… |
Heteromer | 1×506; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with (E)-3-(3-bromo-5-(4-chloro-2-(2-(2… |
Heteromer | 1×1YR; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) varient in Complex with 5-(2-(2-(2,4-dioxo… |
Heteromer | 1×7N1; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in complex with (E)-3-(3-chloro-5-(2-(2-(2,4-dioxo… |
Heteromer | 1×3X6; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (K101P) Variant in Complex with 8-(2-(2-(2,4-dioxo… |
Heteromer | 1×29T; | ||||
| Assess | ||||||
| HIV-1 reverse transcriptase complexed with 4-bromopyrazole |
Heteromer | 1×T27; 15×BYZ; 10×DMS; 3×BR; | ||||
| Assess | ||||||
| Wildtype HIV-1 Reverse Transcriptase in complex with JLJ 578 |
Heteromer | 1×H9Y; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 Reverse Transcriptase in complex with RNA/DNA and dATP |
Heteromer | 1×DTP; 2×MG; 1×EDO; 5×SO4; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 7-((4-((4-cyanophenyl)amino)-1,3,5… |
Heteromer | 1×4XO; 1×MG; 1×SO4; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase (Y181C) varient in Complex with 8-(2-(2-(2,4-dioxo… |
Heteromer | 1×29T; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 8-(2-(2-(2,4-dioxo-3,4-dihydropyri… |
Heteromer | 1×29T; | ||||
| Assess | ||||||
| HIV-1 Reverse Transcriptase Complexed with CP-94,707 |
Heteromer | 1×CP9; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 3-(2-((6-cyanonaphthalen-1-yl)oxy)… |
Heteromer | 1×VWK; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 4-((6-cyanonaphthalen-1-yl)oxy)-3-… |
Heteromer | 1×X2V; | ||||
| Assess | ||||||
| Hexamer HIV-1 CA in complex with CPSF6 peptide and IP6 ligand |
Heteromer Q16630; | 2×IHP; 1×CL; | ||||
| Assess | ||||||
| Crystal Structure of HLA B2705-KK10-L6M |
Heteromer P01889; P61769; | 1×TRS; | ||||
| Assess | ||||||
| Crystal Structure of HLA B2705-KK10 |
Heteromer P01889; P61769; | 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of C12C TCR-HLAB2705-KK10-L6M |
Heteromer P01889; P61769; | 3×SO4; | ||||
| Assess | ||||||
| SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF C… |
Heteromer P03369; | 2×ACT; | ||||
| Assess | ||||||
| KIR3DL1 in complex with HLA-B*57:01-TW10 |
Heteromer P01889; P43629; P61769; | 3×NAG; | ||||
| Assess | ||||||
| Crystal structure of HLA-B*5801 complex with HIV-1 gag derived peptide TW10 |
Heteromer P01889; P61769; | |||||
| Assess | ||||||
| KIR3DL1 in complex with HLA-B*57:01 presenting TSNLQEQIGW |
Heteromer P01889; P43629; P61769; | 3×NAG; | ||||
| Assess | ||||||
| Crystal Structure of C12C TCR-HA B2705-KK10 |
Heteromer P01889; P61769; | |||||
| Assess | ||||||
| Crystal structure of HLA-B*5701 complex with HIV-1 gag derived peptide TW10 |
Heteromer P01889; P61769; | |||||
| Assess | ||||||
| Crystal Structure of HLA B*3505 in complex with NPDIVIYQY, an 9-mer epitope from HIV-I |
Heteromer A0A5H2UI55; P61769; | 2×PEG; 1×TRS; 1×BTB; | ||||
| Assess | ||||||
| Crystal Structure of HLA B*3501 in complex with NPDIVIYQY, an 9-mer epitope from HIV-I |
Heteromer P61769; Q546I9; | 1×FLC; | ||||
| Assess | ||||||
| Crystal Structure of HLA B*3503 in complex with NPDIVIYQY, an 9-mer epitope from HIV-I |
Heteromer A0A6B7FTL9; P61769; | 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of MHC CLass I HLA-A2.1 bound to HIV-1 Peptide RT468-476 |
Heteromer P04439; P61769; | 3×MES; 5×GOL; | ||||
| Assess | ||||||
| Disulfide stabilized HIV-1 CA hexamer in complex with capsid inhibitor N-(1-(3-(4-chloro-1-methyl-3… | homo-6-mer | 18×IOD; 6×9WW; 42×CL; | ||||
| Assess | ||||||
| Disulfide stabilized HIV-1 CA hexamer in complex with capsid inhibitor N-(1-(3-(4-chloro-1-methyl-3… | homo-6-mer | 6×9VI; 24×IOD; 42×CL; | ||||
| Assess | ||||||
| Cryo-EM Structure of the PR-RT components of the HIV-1 Pol Polyprotein | homo-2-mer | |||||
| Assess | ||||||
| HIV-1 RT/9-CL TIBO | homo-2-mer | 1×TB9; | ||||
| Assess | ||||||
| TYR 181 CYS HIV-1 RT/8-CL TIBO | homo-2-mer | 1×TBO; | ||||
| Assess | ||||||
| TYR 188 LEU HIV-1 RT/HBY 097 | homo-2-mer | 1×HBY; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 Reverse Transcriptase (RT) in complex with a Difluoromethylbenzoxazole (… | homo-2-mer | 1×YKN; 1×CA; | ||||
| Assess | ||||||
| HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC204 | homo-2-mer | 1×BFU; | ||||
| Assess | ||||||
| K103N Mutant HIV-1 Reverse Transcriptase in Complex with the Inhibitor PNU142721 | homo-2-mer | 1×PNU; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 Reverse Transcriptase (RT) in complex with a Difluoromethylbenzoxazole (… | homo-2-mer | 1×YKN; 1×CA; | ||||
| Assess | ||||||
| K103N Mutant HIV-1 Reverse Transcriptase in Complex with Efivarenz | homo-2-mer | 1×EFZ; | ||||
| Assess | ||||||
| HIV-1 Reverse Transcriptase in Complex with the Inhibitor MSC194 | homo-2-mer | 1×MSD; | ||||
| Assess | ||||||
| Wild Type HIV-1 Reverse Transcriptase in Complex with Efavirenz | homo-2-mer | 1×EFZ; | ||||
| Assess | ||||||
| HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 | homo-2-mer | 1×HBY; | ||||
| Assess | ||||||
| HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 | homo-2-mer | |||||
| Assess | ||||||
| HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 | homo-2-mer | 1×AAP; | ||||
| Assess | ||||||
| HIV-1 RT/HBY 097 | homo-2-mer | 1×HBY; | ||||
| Assess | ||||||
| Crystal Structure of a 1,2,4-Triazole Allosteric RNase H Inhibitor in Complex with HIV Reverse Tran… | homo-2-mer | 2×MN; 1×T90; | ||||
| Assess | ||||||
| HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND L-METHIONINE TENOFOVIR WITH BOUND MANGANESE | homo-2-mer | 2×MN; 1×RFE; | ||||
| Assess | ||||||
| HIV-1 Reverse Transcriptase in Complex with Manicol at the RNase H Active Site and TMC278 (Rilpivir… | homo-2-mer | 1×MNK; 1×T27; 2×MN; 1×DMS; 1×EDO; | ||||
| Assess | ||||||
| HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of K103N/Y181C mutant of HIV-1 reverse transcriptase in complex with rilpivirine … | homo-2-mer | 1×1BT; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of a 6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione Inhibitor in Complex with H… | homo-2-mer | 1×J63; 1×MG; | ||||
| Assess | ||||||
| HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND D-ASPARTATE TENOFOVIR WITH BOUND MANGANESE | homo-2-mer | 2×MN; 1×REK; | ||||
| Assess | ||||||
| HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND L-GLUTAMATE TENOFOVIR WITH BOUND MANGANESE | homo-2-mer | 2×MN; 1×RE5; | ||||
| Assess | ||||||
| HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND L-METHIONINE TENOFOVIR | homo-2-mer | |||||
| Assess | ||||||
| HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND INHIBITOR RMC-233 | homo-2-mer | |||||
| Assess | ||||||
| HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND L-GLUTAMATE TENOFOVIR | homo-2-mer | |||||
| Assess | ||||||
| HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND INHIBITOR RMC-230 | homo-2-mer | |||||
| Assess | ||||||
| HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND INHIBITOR RMC-259 | homo-2-mer | |||||
| Assess | ||||||
| HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND D-ASPARTATE TENOFOVIR | homo-2-mer | |||||
| Assess | ||||||
| HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND INHIBITOR RMC-264 | homo-2-mer | |||||
| Assess | ||||||
| HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND inhibitor RMC-282 | homo-2-mer | |||||
| Assess | ||||||
| HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND INHIBITOR RMC-247 | homo-2-mer | 1×MN; 1×1IH; | ||||
| Assess | ||||||
| HIV-1 REVERSE TRANSCRIPTASE COMPLEX WITH DNA AND INHIBITOR RMC-257 | homo-2-mer | |||||
| Assess | ||||||
| HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA P… | homo-2-mer | |||||
| Assess | ||||||
| Cryo-EM structure of HIV-1 reverse transcriptase with a DNA aptamer in complex with rilpivirine | homo-2-mer | 1×T27; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase (RT) in complex with a double stranded RNA represe… | homo-2-mer | 1×GLC; 1×MG; | ||||
| Assess | ||||||
| Cryo-EM structure of HIV-1 reverse transcriptase with a DNA aptamer in complex with fragment F04 at… | homo-2-mer | 1×4OI; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 reverse transcriptase in complex with rilpivirine (TMC278) based analogue | homo-2-mer | 1×G73; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165335 | homo-2-mer | 1×65B; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH… | homo-2-mer | 1×MG; 1×IET; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R185545 | homo-2-mer | 1×MG; 1×185; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R147681 | homo-2-mer | 1×TPB; | ||||
| Assess | ||||||
| Cryo-EM structure of HIV-1 reverse transcriptase with a DNA aptamer in complex with doravirine | homo-2-mer | 1×2KW; | ||||
| Assess | ||||||
| Cryo-EM structure of HIV-1 reverse transcriptase with a DNA aptamer in complex with fragment 166 at… | homo-2-mer | 1×3IR; | ||||
| Assess | ||||||
| Cryo-EM Structure of the RT component of the HIV-1 Pol Polyprotein | homo-2-mer | |||||
| Assess | ||||||
| Crystal Structure of HIV-1 Reverse Transcriptase in Complex with 5-(2-(2-(2,4-dioxo-3,4-dihydropyri… | homo-2-mer | 1×3LQ; 2×MG; 4×SO4; | ||||
| Assess | ||||||
| Cryo-EM structure of HIV-1 reverse transcriptase with a DNA aptamer in complex with nevirapine | homo-2-mer | 1×NVP; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R120394. | homo-2-mer | 1×ABZ; | ||||
| Assess | ||||||
| Crystal structures of novel allosteric peptide inhibitors of HIV integrase in the LEDGF binding site | homo-2-mer | 8×SO4; 1×CL; 4×ACY; | ||||
| Assess | ||||||
| Dissociation of biochemical and antiretroviral activities of Integrase-LEDGF Allosteric Inhibitors … | homo-2-mer | 4×MG; 2×9VK; 2×SO4; | ||||
| Assess | ||||||
| Dissociation of biochemical and antiretroviral activities of Integrase-LEDGF Allosteric Inhibitors … | homo-2-mer | 8×MG; 2×9VN; 4×SO4; | ||||
| Assess | ||||||
| Dissociation of biochemical and antiretroviral activities of Integrase-LEDGF Allosteric Inhibitors … | homo-2-mer | 2×MG; | ||||
| Assess | ||||||
| Dissociation of biochemical and antiretroviral activities of Integrase-LEDGF Allosteric Inhibitors … | homo-2-mer | 2×MG; 2×9VN; 2×SO4; | ||||
| Assess | ||||||
| Dissociation of biochemical and antiretroviral activities of Integrase-LEDGF Allosteric Inhibitors … | homo-2-mer | 2×9VK; 2×MG; | ||||
| Assess | ||||||
| Crystal Structure of the HIV-1 Integrase catalytic domain with GSK1264 | homo-2-mer | 2×2SQ; 4×CAC; 2×SO4; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF THE RIBONUCLEASE H DOMAIN OF HIV-1 REVERSE TRANSCRIPTASE | homo-2-mer | |||||
| Assess | ||||||
| crystal structure of HIV protease model precursor/Saquinavir complex | homo-2-mer | 1×ROC; 2×CL; 1×NA; 1×GOL; | ||||
| Assess | ||||||
| crystal structure of HIV model protease precursor/saquinavir complex | homo-2-mer | 2×CL; 1×GOL; 1×ROC; | ||||
| Assess | ||||||
| Crystal structure of HIV protease model precursor/Darunavir complex | homo-2-mer | 3×CL; 1×NA; 1×017; 2×GOL; | ||||
| Assess | ||||||
| Wild Type HIV-1 Protease with Antiviral Drug Amprenavir | homo-2-mer | 1×NA; 3×CL; 1×478; 2×GOL; | ||||
| Assess | ||||||
| HIV-1 wild Type protease with GRL-0648A (a isophthalamide-derived P2-Ligand) | homo-2-mer | 3×NA; 3×CL; 1×GOL; 1×G64; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Protease Mutant I54M with Antiviral Drug Amprenavir | homo-2-mer | 3×CL; 1×NA; 2×ACT; 1×478; | ||||
| Assess | ||||||
| HIV-1 wild Type protease with GRL-031-14A (a Adamantane P1-Ligand with tetrahydropyrano-tetrahydrof… | homo-2-mer | 3×NA; 2×CL; 1×GOL; 1×6KR; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Protease Mutant V32I with Antiviral Drug Amprenavir | homo-2-mer | 1×NA; 3×CL; 1×478; | ||||
| Assess | ||||||
| Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) | homo-2-mer | 3×CL; 1×QHA; | ||||
| Assess | ||||||
| HIV-1 Protease multiple drug resistant clinical isolate mutant PR20 with GRL-14213A | homo-2-mer | 9×Y1; 1×7OA; | ||||
| Assess | ||||||
| Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) | homo-2-mer | 3×CL; 1×C7W; | ||||
| Assess | ||||||
| Crystal structure of wild-type HIV-1 protease with new oxatricyclic designed inhibitor GRL-0519A | homo-2-mer | 1×G52; 2×NA; 6×CL; 2×GOL; | ||||
| Assess | ||||||
| HIV-1 wild Type protease with GRL-0518A , an isophthalamide-derived P2-P3 ligand with the para-hydo… | homo-2-mer | 1×8HD; 2×NA; 3×CL; 2×GOL; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Protease Mutant I50V with Antiviral Drug Amprenavir | homo-2-mer | 3×NA; 7×CL; 2×ACT; 1×478; | ||||
| Assess | ||||||
| HIV-1 wild Type protease with GRL-047-11A (a methylamine bis-Tetrahydrofuran P2-Ligand, 4-amino sul… | homo-2-mer | 1×4UX; 1×NA; 2×CL; 3×ACT; | ||||
| Assess | ||||||
| Crystal structure of multidrug resistant clinical isolate PR20 with GRL-5010A | homo-2-mer | 1×G10; 4×Y1; 5×CL; 1×NA; 2×GOL; | ||||
| Assess | ||||||
| HIV-1 wild Type protease with GRL-050-10A (a Gem-difluoro-bis-Tetrahydrofuran as P2-Ligand) | homo-2-mer | 1×G10; 1×NA; 3×CL; 2×ACT; | ||||
| Assess | ||||||
| 100K X-ray structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with tetrahedral intermediate… | homo-2-mer | 1×KVS; | ||||
| Assess | ||||||
| HIV-1 wild Type protease with GRL-1118A , an isophthalamide-derived P2-P3 ligand with the sulfonami… | homo-2-mer | 1×8FP; 1×NA; 3×CL; 1×GOL; 1×ACT; | ||||
| Assess | ||||||
| HIV-1 wild Type protease with GRL-011-11A (a methylamine bis-Tetrahydrofuran P2-Ligand, sulfonamide… | homo-2-mer | 2×NA; 3×CL; 1×4UY; | ||||
| Assess | ||||||
| Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) | homo-2-mer | 3×CL; 1×ZLP; | ||||
| Assess | ||||||
| Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 with Inhibitor GRL-44… | homo-2-mer | 4×Y1; 5×CL; 2×GOL; 1×G04; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Protease Mutant L90M with Antiviral Drug Amprenavir | homo-2-mer | 19×IOD; 1×478; | ||||
| Assess | ||||||
| New crystal form of HIV-1 Protease/Saquinavir structure reveals carbamylation of N-terminal proline | homo-2-mer | 2×DMS; 1×ROC; 1×CL; | ||||
| Assess | ||||||
| HIV-1 wild type protease with a substituted bis-Tetrahydrofuran inhibitor, GRL-044-10A | homo-2-mer | 1×G04; 1×NA; 2×CL; 3×GOL; | ||||
| Assess | ||||||
| Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) | homo-2-mer | 3×CL; 1×C7L; | ||||
| Assess | ||||||
| Wild-type HIV-1 protease in complex with a substrate analog CA-p2 | homo-2-mer | 1×NA; 2×CL; 1×FMT; 1×0Q4; 1×GOL; | ||||
| Assess | ||||||
| HIV-1 wild Type protease with GRL-097-13A (a Adamantane P1-Ligand with bis-THF in P2 and isobutylam… | homo-2-mer | 1×NA; 2×CL; 1×6KK; | ||||
| Assess | ||||||
| Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) | homo-2-mer | 3×CL; 1×J5L; | ||||
| Assess | ||||||
| Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) | homo-2-mer | 3×CL; 1×VXL; | ||||
| Assess | ||||||
| Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease Inhibitors (II) | homo-2-mer | 3×CL; 1×C7U; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Protease Mutant I54V with Antiviral Drug Amprenavir | homo-2-mer | 19×IOD; 1×478; | ||||
| Assess | ||||||
| Structure of A17 HIV-1 Protease in Complex with Inhibitor KNI-1657 | homo-2-mer | 1×8Z0; 2×GOL; | ||||
| Assess | ||||||
| HIV-1 wild Type protease with GRL-100-13A (a Crown-like Oxotricyclic Core as the P2-Ligand with the… | homo-2-mer | 1×NA; 2×CL; 1×8FM; | ||||
| Assess | ||||||
| HIV-1 wild Type protease with GRL-096-13A (a Boc-derivative P2-Ligand, 3,-5-dimethylbiphenyl P1-Lig… | homo-2-mer | 1×NA; 3×CL; 1×G61; 1×ACT; | ||||
| Assess | ||||||
| Design and Synthesis of P1-P3 Macrocyclic Tertiary Alcohol Comprising HIV-1 Protease Inhibitors | homo-2-mer | 3×CL; 1×M8Y; | ||||
| Assess | ||||||
| Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol | homo-2-mer | 3×CL; 1×1T8; | ||||
| Assess | ||||||
| Design and Synthesis of P1-P3 Macrocyclic Tertiary Alcohol Comprising HIV-1 Protease Inhibitors | homo-2-mer | 3×CL; 1×EQM; | ||||
| Assess | ||||||
| Wild-type HIV-1 protease in complex with a phenylboronic acid (P2') analog of darunavir | homo-2-mer | 1×BVR; 2×CL; 1×GOL; | ||||
| Assess | ||||||
| HIV-1 Protease complexed with Inhibitor: (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(1S,2S)-1-(1-… | homo-2-mer | 1×8BG; | ||||
| Assess | ||||||
| Crystal structure of wild-type HIV-1 protease with a novel HIV-1 inhibitor GRL-14213A of 6-5-5-ring… | homo-2-mer | 1×NA; 2×CL; 1×7OA; 1×ACT; | ||||
| Assess | ||||||
| Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol | homo-2-mer | 3×CL; 1×1T8; | ||||
| Assess | ||||||
| HIV-1 wild Type protease with GRL-007-14A (a Adamantane P1-Ligand with bis-THF in P2 and benzylamin… | homo-2-mer | 2×CL; 1×6KQ; | ||||
| Assess | ||||||
| Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol | homo-2-mer | 3×CL; 1×V78; | ||||
| Assess | ||||||
| Structure of HIV1 protease and hh1_173_3a complex. | homo-2-mer | 1×HH1; | ||||
| Assess | ||||||
| HIV-1 Protease Saquinavir:Ritonavir 1:1 complex structure | homo-2-mer | 1×ROC; 6×CL; 2×DMS; 1×NA; | ||||
| Assess | ||||||
| Two-Carbon-Elongated HIV-1 Protease Inhibitors with a Tertiary- Alcohol-Containing Transition-State… | homo-2-mer | 1×HI1; | ||||
| Assess | ||||||
| Two-Carbon-Elongated HIV-1 Protease Inhibitors with a Tertiary- Alcohol-Containing Transition-State… | homo-2-mer | 1×HV1; | ||||
| Assess | ||||||
| HIV-1 protease in complex with the inhibitor bea403 | homo-2-mer | 1×BED; | ||||
| Assess | ||||||
| Design and Synthesis of P1-P3 Macrocyclic Tertiary Alcohol Comprising HIV-1 Protease Inhibitors | homo-2-mer | 3×CL; 1×M8B; | ||||
| Assess | ||||||
| Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol | homo-2-mer | 3×CL; 1×378; | ||||
| Assess | ||||||
| Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol | homo-2-mer | 3×CL; 1×9MW; | ||||
| Assess | ||||||
| HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitor | homo-2-mer | 1×BE4; | ||||
| Assess | ||||||
| HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitor | homo-2-mer | 1×BE3; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH INHIBITOR, AHA024 | homo-2-mer | 1×AHF; | ||||
| Assess | ||||||
| INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF… | homo-2-mer | 1×A79; | ||||
| Assess | ||||||
| HIV-1 protease in complex with the inhibitor MSA367 | homo-2-mer | 1×MS3; | ||||
| Assess | ||||||
| HIV-1 protease in complex with the inhibitor MSL370 | homo-2-mer | 1×MSC; | ||||
| Assess | ||||||
| HIV-1 Protease in complex with the inhibitor BEA435 | homo-2-mer | 1×BEH; | ||||
| Assess | ||||||
| HIV-1 protease in complex with the inhibitor BEA322 | homo-2-mer | 1×BEI; | ||||
| Assess | ||||||
| HIV-1 protease in complex with the inhibitor BEA425 | homo-2-mer | 1×BEG; | ||||
| Assess | ||||||
| Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol | homo-2-mer | 3×CL; 1×V78; | ||||
| Assess | ||||||
| Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol | homo-2-mer | 3×CL; 1×J3W; | ||||
| Assess | ||||||
| X-ray crystal structure of wild type HIV-1 protease in complex with GRL-087-13 | homo-2-mer | 1×FQ4; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Protease Mutant I84V with Antiviral Drug Amprenavir | homo-2-mer | 1×478; 30×IOD; | ||||
| Assess | ||||||
| Structural and kinetic analysis of drug resistant mutants of HIV-1 protease | homo-2-mer | 1×0Q4; | ||||
| Assess | ||||||
| HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP323 | homo-2-mer | 1×DMP; | ||||
| Assess | ||||||
| HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitor | homo-2-mer | 1×BE6; | ||||
| Assess | ||||||
| HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitor | homo-2-mer | 1×BE5; | ||||
| Assess | ||||||
| HIV-1 MUTANT (V82F, I84V) PROTEASE COMPLEXED WITH DMP323 | homo-2-mer | 1×DMP; | ||||
| Assess | ||||||
| HIV-1 MUTANT (V82F) PROTEASE COMPLEXED WITH DMP323 | homo-2-mer | 1×DMP; | ||||
| Assess | ||||||
| HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP450 | homo-2-mer | 1×DMQ; | ||||
| Assess | ||||||
| D30N HIV-1 protease in complex with a phenylboronic acid (P2') analog of darunavir | homo-2-mer | 3×CL; 1×BVR; 1×GOL; | ||||
| Assess | ||||||
| X-ray crystal structure of wild type HIV-1 protease in complex with GRL-084-13 | homo-2-mer | 1×FQ1; | ||||
| Assess | ||||||
| Crystal Structure of Complex of a Hydroxyethylamine Inhibitor with HIV-1 Protease at 2.0A Resolution | homo-2-mer | 1×0ZS; | ||||
| Assess | ||||||
| Structure of HIV-1 protease bound to atazanavir | homo-2-mer | 1×DR7; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 protease complexed with LDC271 | homo-2-mer | 1×L27; | ||||
| Assess | ||||||
| STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITHAN EFFICIENT INHIBITOR OF FIV PR | homo-2-mer | 2×3TL; | ||||
| Assess | ||||||
| HIV-1 protease in complex with the inhibitor BEA428 | homo-2-mer | 1×BEJ; | ||||
| Assess | ||||||
| ACTIVE-SITE MOBILITY IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE AS DEMONSTRATED BY CRYSTAL STR… | homo-2-mer | 2×U0E; | ||||
| Assess | ||||||
| crystal structure of HIV-1 protease-hup | homo-2-mer | 1×3NH; | ||||
| Assess | ||||||
| X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN-DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PRO… | homo-2-mer | 2×G37; | ||||
| Assess | ||||||
| Crystal structure of HIV protease complexed with LGZ479 | homo-2-mer | 1×LGZ; | ||||
| Assess | ||||||
| HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC SULFAMIDE INHIBITOR AHA006 | homo-2-mer | 1×NMB; | ||||
| Assess | ||||||
| HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC UREA INHIBITOR AHA001 | homo-2-mer | 1×AH1; | ||||
| Assess | ||||||
| HIV-1 protease in complex with the inhibitor BEA388 | homo-2-mer | 1×BEC; | ||||
| Assess | ||||||
| HIV Protease with Scripps AB-3 Inhibitor | homo-2-mer | 2×A83; | ||||
| Assess | ||||||
| Crystal structure of wild type HIV-1 protease (BRU isolate) with a hydroxyethylamine peptidomimetic… | homo-2-mer | 1×0ZT; | ||||
| Assess | ||||||
| Structural and kinetic analysis of drug resistant mutants of HIV-1 protease | homo-2-mer | 1×0Q4; | ||||
| Assess | ||||||
| HIV-1 protease in complex with an isobutyl decorated oligoamine (symmetric binding mode) | homo-2-mer | 2×LJG; 2×CL; | ||||
| Assess | ||||||
| HIV-1 protease in complex with the inhibitor BEA409 | homo-2-mer | 1×BEE; | ||||
| Assess | ||||||
| Crystal Structure of HIV Protease complexed with Arylsulfonamide azacyclic urea | homo-2-mer | 1×BH0; | ||||
| Assess | ||||||
| COMPARATIVE ANALYSIS OF THE X-RAY STRUCTURES OF HIV-1 AND HIV-2 PROTEASES IN COMPLEX WITH CGP 53820… | homo-2-mer | 2×BME; 1×C20; | ||||
| Assess | ||||||
| The crystal structures at 2.2 angstroms resolution of hydroxyethylene-based inhibitors bound to hum… | homo-2-mer | 2×PSI; | ||||
| Assess | ||||||
| X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN-DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PRO… | homo-2-mer | 2×G26; | ||||
| Assess | ||||||
| The crystal structures at 2.2 angstroms resolution of hydroxyethylene-based inhibitors bound to hum… | homo-2-mer | |||||
| Assess | ||||||
| HIV-1 protease in complex with the inhibitor BEA369 | homo-2-mer | 1×BEB; | ||||
| Assess | ||||||
| RATIONAL DESIGN, SYNTHESIS AND CRYSTALLOGRAPHIC ANALYSIS OF A HYDROXYETHYLENE-BASED HIV-1 PROTEASE … | homo-2-mer | 2×RUN; | ||||
| Assess | ||||||
| HIV-1 PROTEASE MUTANT WITH VAL 82 REPLACED BY ASN (V82N) COMPLEXED WITH U89360E (INHIBITOR) | homo-2-mer | 2×U0E; | ||||
| Assess | ||||||
| HIV-1 PROTEASE (WILD TYPE) COMPLEXED WITH U89360E (INHIBITOR) | homo-2-mer | 2×U0E; | ||||
| Assess | ||||||
| AN ORALLY-BIOAVAILABLE HIV-1 PROTEASE INHIBITOR CONTAINING AN IMIDAZOLE-DERIVED PEPTIDE BOND REPLAC… | homo-2-mer | 1×IM1; | ||||
| Assess | ||||||
| HIV-1 PROTEASE MUTANT WITH VAL 82 REPLACED BY ASP (V82D) COMPLEXED WITH U89360E (INHIBITOR) | homo-2-mer | 2×U0E; | ||||
| Assess | ||||||
| A CHECK ON RATIONAL DRUG DESIGN. CRYSTAL STRUCTURE OF A COMPLEX OF HIV-1 PROTEASE WITH A NOVEL GAMM… | homo-2-mer | 1×GAN; | ||||
| Assess | ||||||
| G48H MUTANT OF HIV-1 PROTEASE IN COMPLEX WITH A PEPTIDIC INHIBITOR U-89360E | homo-2-mer | 1×U0E; | ||||
| Assess | ||||||
| INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE BY A C2-SYMMETRIC PHOSPHINATE SYNTHESIS AND C… | homo-2-mer | 1×PHP; | ||||
| Assess | ||||||
| Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol | homo-2-mer | 3×CL; 1×9MW; | ||||
| Assess | ||||||
| Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol | homo-2-mer | 3×CL; 1×M17; | ||||
| Assess | ||||||
| HIV Protease inhibitors with pseudo-symmetric cores | homo-2-mer | 1×GGW; | ||||
| Assess | ||||||
| HIV Protease, pseudo-symmetric inhibitors | homo-2-mer | 1×GGX; | ||||
| Assess | ||||||
| X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN-DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PRO… | homo-2-mer | 1×G23; | ||||
| Assess | ||||||
| HIV Protease (PR) in open form with Mg2+ in active site and HIVE-9 in eye site | homo-2-mer | 1×3TL; 1×HV9; 1×DMS; | ||||
| Assess | ||||||
| HIV Protease with oximinoarylsulfonamide bound | homo-2-mer | 1×OIS; | ||||
| Assess | ||||||
| HIV Protease, pseudo-symmetric inhibitors | homo-2-mer | 1×GGV; | ||||
| Assess | ||||||
| C-terminal DNA-binding domain of HIV-1 integrase, NMR, 42 structures | homo-2-mer | |||||
| Assess | ||||||
| 2.2 ANGSTROMS RESOLUTION STRUCTURE OF THE AMINO-TERMINAL HALF OF HIV-1 REVERSE TRANSCRIPTASE (FINGE… | monomer | |||||
| Assess | ||||||
| Structure of a dihydroxycoumarin active-site inhibitor in complex with the RNASE H domain of HIV-1 … | monomer | 2×MN; 1×F95; | ||||
| Assess | ||||||
| HIV-1 Reverse Transcriptase Isolated RnaseH Domain with the Inhibitor beta-thujaplicinol Bound at t… | monomer | 2×MN; 1×JTH; | ||||
| Assess | ||||||
| CRYSTALLOGRAPHIC ANALYSES OF AN ACTIVE HIV-1 RIBONUCLEASE H DOMAIN SHOW STRUCTURAL FEATURES THAT DI… | monomer | |||||
| Assess | ||||||
| Structural insights into the cTAR DNA recognition by the HIV-1 Nucleocapsid protein: role of sugar … | monomer | 2×ZN; | ||||
| Assess | ||||||
| How the HIV-1 nucleocapsid protein binds and destabilises the (-)primer binding site during reverse… | monomer | 2×ZN; | ||||
| Assess | ||||||
| Solution structure of the HIV-1 nucleocapsid (NCp7(12-55)) complexed with the DNA (-) Primer Bindin… | monomer | 2×ZN; | ||||
| Assess | ||||||
| C-terminal zinc knuckle of the HIVNCp7 with DNA | monomer | 1×ZN; | ||||
| Assess | ||||||
| C-terminal zinc finger of the HIVNCp7 with platinated DNA | monomer | 1×ZN; | ||||
| Assess | ||||||
6 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7t15.1.E | homo-6-mer | 0.73 | 84.42 | |||
| Assess | ||||||
| 6v3k.3.A | homo-4-mer | 0.72 | 92.28 | |||
| Assess | ||||||
| 7sep.1.A | homo-2-mer | 0.71 | 99.69 | |||
| Assess | ||||||
| 5u1c.1.A | homo-4-mer | 0.70 | 91.91 | |||
| Assess | ||||||
| 1l6n.1.A | monomer | 0.69 | 96.11 | |||
| Assess | ||||||
| 7asl.1.A | homo-18-mer | 0.66 | 99.15 | |||
| Assess | ||||||